Thrombocytopenia in homosexual men. NLM AIDSLINE Important note: Information in this article was accurate in 1986. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Thrombocytopenia in homosexual men.

Am J Hematol. 1986 Mar;21(3):243-7. Unique Identifier : AIDSLINE MED/86127286
Goldsweig HG; Grossman R; William D

Abstract: The office records of two private practices with a preponderance of homosexual patients were reviewed for cases of males with unexplained thrombocytopenia. Twenty-five patients meeting the selection criteria were found. The clinical and laboratory features of these patients were reviewed and compared to those characteristically seen in classic autoimmune thrombocytopenic purpura. The mean age of the group was 36.5 years. There was a high incidence of a history of sexually transmitted diseases. Sixty percent had another hematologic abnormality in addition to thrombocytopenia. The clinical outcomes for these 25 patients were as follows: eight (32%) had a spontaneous increase in platelets; four (16%) had a stable count not requiring therapy; 12 (48%) received high-dose prednisone; seven (28%) failed prednisone therapy and went on to splenectomy; two (8%) subsequently developed CDC-defined AIDS.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS Adult Age Factors Bone Marrow/CYTOLOGY *Homosexuality Human Male Middle Age New York Platelet Count Prednisone/THERAPEUTIC USE Thrombocytopenia/DRUG THERAPY/*EPIDEMIOLOGY JOURNAL ARTICLE

KWDacquiredimmunodeficiencysyndrome/complicationsadultagefactorsbonemarrow/cytologyKWDhomosexualityhumanmalemiddleagenewyorkplateletcountprednisone/therapeuticusethrombocytopenia/drugtherapy/KWDepidemiologyjournalarticle
860530
M8650151

Copyright © 1986 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1986. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1986. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .